SCHEMBL20127658

SCHEMBL20127658

c1cc(-c2ccc3c4ccccc4c4ccccc4c3c2)cc(-c2c3ccccc3c(-c3c4oc5ccccc5c4cc4c3oc3ccccc34)c3ccccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.41
PLA2G4A P47712 5/20 0.41
PLA2G10 O15496 1/20 0.41
ALOX5 P09917 2/20 0.40
AHR P35869 2/20 0.39
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PGR P06401 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
DYRK1A Q13627 1/20 0.33
CSF1R P07333 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
FLT3 P36888 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127641 0.94 AHR (0.42) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL23509138 0.93 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL20127663 0.91 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL20127650 0.91 AHR (0.41) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL10122335 0.90 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL20127456 0.89 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL10122632 0.89 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL20127628 0.87 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL15498111 0.86 AHR (0.46) PLA2G2APLA2G4APLA2G10ALOX5AHR
SCHEMBL10122331 0.86 HSD17B1 (0.40) PLA2G2APLA2G4APLA2G10ALOX5AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 PLA2G2A 2960/4885PLA2G4A 3780/4885PLA2G10 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.